Rivaroxaban

Details

Files

Generic Name:

Rivaroxaban

Project Status:

Complete

Therapeutic Area:

Deep-vein thrombosis without symptomatic pulmonary embolism

Manufacturer:

Bayer Inc.

Call for patient/clinician input open:

February 16, 2012

Brand Name:

Xarelto

Project Line:

Reimbursement Review

Project Number:

SR0271-000

Call for patient/clinician input closed:

March 20, 2012

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Deep-Vein Thrombosis (treatment), without Symptomatic Pulmonary Embolism

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

August 16, 2012

Last Updated : February 27, 2012